Article Details
Retrieved on: 2024-10-05 11:39:35
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... biopharma portfolio in the U.S. and worldwide.” OTULFI is the fourth STELARA® biosimilar approved in the United States, following Amgen's WEZLANA ...
Article found on: www.goodwinlaw.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here